• Molecular NameArbekacin
  • SynonymArbekacina; Arbekacine; Arbekacinum; Habekacin; Haberacin
  • Weight552.626
  • Drugbank_IDN/A
  • ACS_NO51025-85-5
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-8.03
  • pkaN/A
  • LogD (pH=7, predicted)-14.3
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.26
  • LogSw (predicted, AB/LogsW2.0)1113.52
  • Sw (mg/ml) (predicted, ACD/Labs)1000.0
  • No.of HBond Donors16
  • No.of HBond Acceptors16
  • No.of Rotatable Bonds10
  • TPSA297.27
  • StatusN/A
  • AdministrationIntramuscular, intravenous
  • PharmacologyA semisynthetic aminoglycoside antibiotic. It is primarily used for the treatment of infections caused by multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA).
  • Absorption_value0.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability0.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • Metabollsmminimal
  • Half lifeN/A
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A